Abdel-Ghani Azzouqa, MBBS

  • Rapid City, SD
  • Hematologist and oncologist
NPI1720428170PAC ID7911298773
Medicare services, 2024
1,891
Medicare patients, 2024
322
Part D claims, 2024
1,104
Publications
8
Clinical trials
5
Practice address
353 Fairmont Blvd, Rapid City, SD 57701
Practice phone
Call (605) 755-1000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Monument Health Rapid City Hospital

Hospital · Rapid City, South Dakota

See all 6 affiliations

Find Abdel-Ghani Azzouqa's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Abdel-Ghani Azzouqa is a hematologist and oncologist in Rapid City, South Dakota

Abdel-Ghani Azzouqa practices at Monument Health Rapid City Hospital in Rapid City, South Dakota, part of Monument Health.

Abdel-Ghani Azzouqa's NPI, 1720428170, was assigned on June 30, 2013. Abdel-Ghani Azzouqa graduated from Jordan University of Science and Technology FOM in 2011. Abdel-Ghani Azzouqa's Florida license number on file is ME127985.

NPI and contact details
Medicare PAC ID
7911298773
NPI enumeration date
June 30, 2013
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(605) 755-1000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
41
Medical school graduation
2011

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Abdel-Ghani Azzouqa practices at Monument Health Rapid City Hospital in Rapid City, South Dakota

Abdel-Ghani Azzouqa's primary practice is Monument Health Rapid City Hospital, at 353 Fairmont Blvd, Rapid City, SD 57701 in Pennington County. The practice phone is (605) 755-1000.

Source: Dmand AI Affiliation Data

Abdel-Ghani Azzouqa is affiliated with 5 sites of care and 1 medical group

Abdel-Ghani Azzouqa's primary practice is Monument Health Rapid City Hospital in Rapid City, South Dakota, part of Monument Health. Abdel-Ghani Azzouqa is also affiliated with Monument Health Spearfish Hospital. The medical group on file is Monument Health Rapid City Hospital. Dmand AI also links Abdel-Ghani Azzouqa to 3 more hospitals, each named with a free account.

See all 6 affiliations for Abdel-Ghani Azzouqa

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Abdel-Ghani Azzouqa's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Abdel-Ghani Azzouqa practices, 5 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Monument Health Rapid City HospitalAvailable with a free account
+4 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Abdel-Ghani Azzouqa practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Monument Health and 6.2K+ hospitals, with verified contacts in the same login.

Abdel-Ghani Azzouqa is one of 34 hematologists and oncologists in South Dakota

Hematology and oncology is Abdel-Ghani Azzouqa's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Abdel-Ghani Azzouqa is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Abdel-Ghani Azzouqa's licenses on file in 3 states: Florida, South Dakota and Ohio.

Specialties and state licenses

  • Hematology and oncology, FloridaPrimaryLicense ME127985 · 2016 to 2020 · taxonomy 207RH0003X
  • South Dakota license
  • Ohio license2013 to 2016

Clinical focus

Dmand AI lists arterial blot clot /embolism, breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma and multiple myeloma among the conditions Abdel-Ghani Azzouqa treats.

Hematologists and oncologists near Abdel-Ghani Azzouqa

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Abdel-Ghani Azzouqa billed Medicare for 1,891 services in 2024

CMS data shows 1,891 Medicare services from Abdel-Ghani Azzouqa across 5 procedure codes in 2024, for 322 Medicare patients. Medicare paid $98,420 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 20241,891
Medicare patients322
Paid by Medicare$98,420
Procedure codes5

Abdel-Ghani Azzouqa's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 1,0432024: 1,0692%
Other services
2023: 02024: 822

Abdel-Ghani Azzouqa compared with the South Dakota median for hematologists and oncologists, 2024

  • Abdel-Ghani Azzouqa
  • South Dakota median
Medicare services
1,891vs 1,02285% above
Medicare patients
322vs 332Close to median
Part D claims
842vs 61836% above

Medians across 33 hematologists and oncologists in South Dakota with Dmand AI profiles that report each measure.

Abdel-Ghani Azzouqa's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Abdel-Ghani Azzouqa

Need commercial claims for Abdel-Ghani Azzouqa?

Medicare shows one payer. Book a meeting to get commercial claims data for Abdel-Ghani Azzouqa and other hematologists and oncologists in South Dakota.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Abdel-Ghani Azzouqa treated 322 Medicare patients in 2024, average age 74

CMS counts 322 Medicare patients who saw Abdel-Ghani Azzouqa in 2024. The largest group is 65 to 74, with 155 patients. 74% of them have high blood pressure, and 68% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Abdel-Ghani Azzouqa's median patient age at 75, with 50% women.

Medicare patients, 2024322
Average age74
Average risk score2.23
Also on Medicaid8%

Abdel-Ghani Azzouqa's Medicare patients by age, 2024

Abdel-Ghani Azzouqa's Medicare patients by sex, 2024

  • Women16852%
  • Men15448%

Chronic conditions among Abdel-Ghani Azzouqa's Medicare patients, 2024

  1. High blood pressure74%
  2. High cholesterol68%
  3. Cancer60%
  4. Arthritis39%
  5. Diabetes29%
  6. Osteoporosis25%
  7. Mood disorders24%
  8. Depression22%

Share of Medicare patients with each condition. A patient can have several.

Abdel-Ghani Azzouqa's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 75

Patient panel by sex, all payers

  • Women50%
  • Men50%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Abdel-Ghani Azzouqa wrote 1,104 Medicare Part D claims in 2024

In 2024, Abdel-Ghani Azzouqa wrote 1,104 Medicare Part D claims for 206 patients. 69% of them were for generic drugs. CMS names the drug for 842 of them, across 28 drugs with 11 or more claims each, at $3,200,891 in total drug cost. In 2023, CMS named 909 claims across 30 drugs.

Part D claims, 20241,104
Drugs named by CMS28
Total drug cost$3.2M
Part D patients206

Abdel-Ghani Azzouqa's Part D claims by kind of drug, 2024

  • Generic767 claims69%
  • Brand-name and other337 claims31%

Abdel-Ghani Azzouqa's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Abdel-Ghani Azzouqa's Part D claims, 2024

  • Opioids4%39 of 1,104 claims
  • Antibiotics3%34 of 1,104 claims
  • Antipsychotics, patients 65 and over3%28 of 1,104 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 9092024: 8427%

Drugs named by CMS: 28 in 2024, 30 in 2023.

See all prescribing by Abdel-Ghani Azzouqa

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Abdel-Ghani Azzouqa scored 94 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Abdel-Ghani Azzouqa for performance year 2024, reported through an alternative payment model (APM). Abdel-Ghani Azzouqa accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Abdel-Ghani Azzouqa's MIPS scores, performance year 2024

  • 94of 100Final score
  • 80.4of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Abdel-Ghani Azzouqa by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Abdel-Ghani Azzouqa has 8 publications on record

Dmand AI links 8 papers to Abdel-Ghani Azzouqa, published from 2016 to 2024. 2018 was the busiest year, with 2. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols and Multiple Myeloma. Abdel-Ghani Azzouqa's most frequent co-authors are Vivek Roy, MD, Meghna Ailawadhi, MD and Sikander Ailawadhi, MD.

Papers8
Years published2016 to 2024

Abdel-Ghani Azzouqa's papers by year, 2016 to 2024

Topics Abdel-Ghani Azzouqa writes about most

  • Antineoplastic Combined Chemotherapy Protocols
  • Multiple Myeloma

Abdel-Ghani Azzouqa's most frequent co-authors

Recent publications by Abdel-Ghani Azzouqa

See all 8 publications and co-authors

See who Abdel-Ghani Azzouqa researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Abdel-Ghani Azzouqa works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Abdel-Ghani Azzouqa has worked on 5 clinical trials

Dmand AI links Abdel-Ghani Azzouqa to 5 clinical trials, 4 of them phase 3 studies. 5 are still active or recruiting. Conditions studied include Lung Neoplasms, Lymphatic Metastasis and Oligodendroglioma. Alliance for Clinical Trials in Oncology sponsors the most, 2.

Clinical trials with Abdel-Ghani Azzouqa by phase

  1. NonePhase 1: no trials
  2. NonePhase 2: no trials
  3. 1Phase 2/3: 1 trial
  4. 4Phase 3: 4 trials
  5. NonePhase 4: no trials

Conditions in Abdel-Ghani Azzouqa's trials

  • Lung Neoplasms
  • Lymphatic Metastasis
  • Oligodendroglioma
  • Astrocytoma
  • Carcinoma, Renal Cell

Investigators on the most trials with Abdel-Ghani Azzouqa

Recent clinical trials with Abdel-Ghani Azzouqa

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Abdel-Ghani Azzouqa received $1,372 in industry payments from 2017 to 2025

CMS Open Payments shows 42 general payments to Abdel-Ghani Azzouqa from 23 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 83% of the total. Eli Lilly and Company paid the most, $336.

General payments to Abdel-Ghani Azzouqa by program year, 2017 to 2025

General payments to Abdel-Ghani Azzouqa by kind, 2017 to 2025

$1.4Kin total
  • Food and beverage$1,13383%
  • Education$23917%

Companies that paid Abdel-Ghani Azzouqa the most, 2017 to 2025

Share is of all general payments to this clinician.

See all payments to Abdel-Ghani Azzouqa

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Abdel-Ghani Azzouqa has 2 awards and honors on record

Dmand AI lists 2 awards for Abdel-Ghani Azzouqa.

Awards and honors for Abdel-Ghani Azzouqa

  1. Undated
    • First Place Winner-The Sarcoma Super Bowl
    • Recognition award for Teamwork

Source: Dmand AI Professional Profile Data

Abdel-Ghani Azzouqa graduated from Jordan University of Science and Technology FOM

Abdel-Ghani Azzouqa graduated from Jordan University of Science and Technology FOM in 2011. Abdel-Ghani Azzouqa is a member of AMA, ASCO and ASH.

  1. Medical schoolJordan University of Science and Technology FOM
  2. Board certified in hematologyAmerican Board of Internal Medicine
  3. Board certified in internal medicineAmerican Board of Internal Medicine
  4. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Abdel-Ghani Azzouqa accepts plans from 15 insurance carriers

Abdel-Ghani Azzouqa is in network with 15 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.

  • Aetna
  • United Healthcare
  • Blue Cross Blue Shield of Michigan
  • Elevance
  • HCSC
  • Medica
  • Alliant Health Plans
  • Blue Cross Blue Shield of Massachusetts
  • +7 more carriersWith a free account

Plan types Abdel-Ghani Azzouqa accepts, by number of carriers

  1. PPO11
  2. HMO7
  3. Medicare7
  4. POS5
  5. EPO4
  6. Medicaid1

Source: Dmand AI Insurance Network Data

Sources for Abdel-Ghani Azzouqa's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Abdel-Ghani Azzouqa

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Abdel-Ghani Azzouqa's NPI number?

Abdel-Ghani Azzouqa's NPI number is 1720428170. It was assigned on June 30, 2013, and it is active in the NPI Registry.

What does Abdel-Ghani Azzouqa specialize in?

Abdel-Ghani Azzouqa is a hematologist and oncologist in Rapid City, South Dakota. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Abdel-Ghani Azzouqa practice?

Abdel-Ghani Azzouqa practices at 353 Fairmont Blvd, Rapid City, SD 57701. Abdel-Ghani Azzouqa's primary practice is Monument Health Rapid City Hospital in Rapid City, South Dakota, part of Monument Health. Dmand AI also links Abdel-Ghani Azzouqa to 3 hospitals.

What is Abdel-Ghani Azzouqa's office phone number?

The practice phone on file for Abdel-Ghani Azzouqa is (605) 755-1000.

What is Abdel-Ghani Azzouqa's medical license number?

Abdel-Ghani Azzouqa's Florida license number on file is ME127985, one of the licenses on file in 3 states.

Which states has Abdel-Ghani Azzouqa been licensed in?

Dmand AI has state licenses on file for Abdel-Ghani Azzouqa in Florida (2016 to 2020), South Dakota and Ohio (2013 to 2016).

Which hospitals is Abdel-Ghani Azzouqa affiliated with?

Abdel-Ghani Azzouqa practices at Monument Health Rapid City Hospital in Rapid City, South Dakota. Abdel-Ghani Azzouqa is also affiliated with Monument Health Spearfish Hospital. Dmand AI links Abdel-Ghani Azzouqa to 3 more hospitals.

What medical group is Abdel-Ghani Azzouqa part of?

Abdel-Ghani Azzouqa is linked to Monument Health Rapid City Hospital.

Does Abdel-Ghani Azzouqa accept Medicare?

Yes. CMS data shows Abdel-Ghani Azzouqa billed Medicare for 1,891 services in 2024, and Abdel-Ghani Azzouqa accepts Medicare assignment.

What is Abdel-Ghani Azzouqa's MIPS score?

Abdel-Ghani Azzouqa's MIPS final score for performance year 2024 is 94 out of 100, reported through an alternative payment model (APM).

Show 10 more questionsShow fewer questions

How many Medicare patients does Abdel-Ghani Azzouqa see?

CMS counts 322 Medicare patients who saw Abdel-Ghani Azzouqa in 2024, with an average age of 74.

Is Abdel-Ghani Azzouqa board certified?

Yes. Abdel-Ghani Azzouqa is board certified in hematology by the American Board of Internal Medicine.

What services does Abdel-Ghani Azzouqa bill to Medicare?

In 2024, Abdel-Ghani Azzouqa's most billed Medicare services were medicare service (G2211), office visit, established patient (99214) and office visit, established patient (99215).

Where did Abdel-Ghani Azzouqa go to medical school?

Abdel-Ghani Azzouqa graduated from Jordan University of Science and Technology FOM in 2011.

What drugs does Abdel-Ghani Azzouqa prescribe most?

In 2024 Medicare Part D data, Abdel-Ghani Azzouqa's most prescribed drugs by claims were Prochlorperazine Maleate, Ondansetron HCl and Prednisone.

Has Abdel-Ghani Azzouqa received payments from drug or device companies?

CMS Open Payments shows $1,372 in general payments to Abdel-Ghani Azzouqa from 23 companies from 2017 to 2025. The largest total came from Eli Lilly and Company.

How long has Abdel-Ghani Azzouqa been practicing?

Abdel-Ghani Azzouqa graduated from medical school in 2011, 15 years ago.

Does Abdel-Ghani Azzouqa do research?

Dmand AI links 8 publications to Abdel-Ghani Azzouqa, published from 2016 to 2024. Abdel-Ghani Azzouqa has worked on 5 clinical trials.

Who does Abdel-Ghani Azzouqa publish with?

Abdel-Ghani Azzouqa's most frequent co-authors are Vivek Roy, MD (3 shared papers), Meghna Ailawadhi, MD (2 shared papers) and Sikander Ailawadhi, MD (2 shared papers).

What insurance does Abdel-Ghani Azzouqa accept?

Abdel-Ghani Azzouqa is in network with 15 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in South Dakota by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)